0001093557-15-000370.txt : 20151117
0001093557-15-000370.hdr.sgml : 20151117
20151117193243
ACCESSION NUMBER: 0001093557-15-000370
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151113
FILED AS OF DATE: 20151117
DATE AS OF CHANGE: 20151117
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DEXCOM INC
CENTRAL INDEX KEY: 0001093557
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330857544
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582000200
MAIL ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GREGG TERRANCE H
CENTRAL INDEX KEY: 0001236388
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51222
FILM NUMBER: 151239366
MAIL ADDRESS:
STREET 1: AMYLIN PHARMACEUTICALS INC
STREET 2: 9360 TOWNE CENTRE DR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2015-11-13
0
0001093557
DEXCOM INC
DXCM
0001236388
GREGG TERRANCE H
6340 SEQUENCE DRIVE
SAN DIEGO
CA
92121
1
1
0
0
Executive Chairman
Common Stock
2015-11-13
4
M
0
5000.0
6.85
A
464018
D
Common Stock
2015-11-13
4
S
0
5000.0
85.0967
D
459018
D
Common Stock
2015-11-16
4
S
0
15000.0
83.4851
D
316064
I
by Trust
Common Stock
11461
I
by IRA
Non-Qualified Stock Option (right to buy)
6.85
2015-11-13
4
M
0
5000.0
85.0967
D
2008-06-19
2017-06-19
Common Stock
5000
77500
D
Included in this number are 136,564 unvested restricted stock units, 35,000 of which were granted on March 8, 2015 and will vest on March 8, 2016, 81,251 unvested restricted stock units granted on March 8, 2014, 5,078 of which shall vest each month through March 8, 2017, and 20,313 unvested restricted stock units granted on March 11, 2013, 5,078 of which shall vest each month through March 11, 2016.
On December 12, 2014, Mr. Gregg adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Gregg. The shares set forth above were sold pursuant to the 10b5-1 Plan.
This transaction was executed in multiple trades at prices ranging from $82.88 to $84.56. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.
By: Jess Roper For: Terrance H. Gregg
2015-11-17